NT100

NT100 is a novel investigational drug developed by Nora Therapeutics, primarily studied in the context of reproductive immunology and fertility. It is being evaluated as a potential treatment to improve pregnancy outcomes, particularly for women with recurrent pregnancy loss or implantation failure. The mechanism of action and molecular details are not fully disclosed in public sources, but it is positioned as an emerging pharmaceutical candidate with applications in reproductive medicine[10][9]. There are also references to "NT 100" as an imprint on nitrofurantoin capsules; however, these refer to a different product (nitrofurantoin macrocrystals) and not the investigational drug from Nora Therapeutics[1].

Brand names

NT100NT-100NT 100